4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-014941
Director sold 62,590 shares at $36.07 ($2,257,621)
- Director acquired 62,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MARCUS JOEL S Director | 2019-02-27 | Option exercise | +25,000 | $25.15 | $628,750 | 32,590 | D |
| MARCUS JOEL S Director | 2019-02-27 | Option exercise | +10,500 | $24.05 | $252,525 | 43,090 | D |
| MARCUS JOEL S Director | 2019-02-27 | Option exercise | +5,500 | $15.08 | $82,940 | 48,590 | D |
| MARCUS JOEL S Director | 2019-02-27 | Option exercise | +21,500 | $13.20 | $283,800 | 70,090 | D |
| MARCUS JOEL S Director | 2019-02-28 | Sale | −62,590 | $36.07 | $2,257,621 | 7,500 | D |
| Derivatives | |||||||
| MARCUS JOEL S Director | 2019-02-27 | Option exercise · Non-Qualified Stock Option (Right to Buy) | −25,000 | 0 | D | ||
| MARCUS JOEL S Director | 2019-02-27 | Option exercise · Non-Qualified Stock Option (Right to Buy) | −10,500 | 0 | D | ||
| MARCUS JOEL S Director | 2019-02-27 | Option exercise · Non-Qualified Stock Option (Right to Buy) | −5,500 | 0 | D | ||
| MARCUS JOEL S Director | 2019-02-27 | Option exercise · Non-Qualified Stock Option (Right to Buy) | −21,500 | 0 | D | ||
| Open-market sales · 62,590 sh · avg $36.07 · $2,257,621 | |||||||
Loading xslF345X03/doc4.xml…